Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Over 50 years of research and 70+ published studies support its safety at therapeutic doses
Patient Support How responsive and helpful is their support team
At least four other candidates are in trials
22 Patients Without ASCVD/Indicators of High Risk, HF, or CKD For patients without ASCVD/indicators of high risk, HF, or CKD, the addition of glucose-lowering agents is based on the need for additional glucose lowering to maintain glycemic goals
US$ 21.31
US$ 26.60
US$ 21.09
US$ 24.66
US$ 29.86
US$ 25.14
US$ 23.46
US$ 28.68
US$ 26.28
US$ 23.91
US$ 25.09
